<DOC>
	<DOCNO>NCT00679718</DOCNO>
	<brief_summary>To evaluate efficacy safety INS365 Ophthalmic Solution apply topically patient moderate severe dry eye disease .</brief_summary>
	<brief_title>A Study INS365 Ophthalmic Solution Patients With Moderate Severe Dry Eye Disease</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Best correct visual acuity least +0.7 ETDRS Six month history dry eye disease Mild severity two five symptom Unanesthetized Schirmer score less equal 7mm Corneal fluorescein stain great equal 4 15 lissamine green conjunctival stain great equal 5 18 Nasal stimulate Schirmer score le 3mm Have ongoing ocular infection Have congenitally absent meibomian lacrimal gland Have punctal occlusion within specified time prior study Wear contact lens refuse remove Have exclude eye condition .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>